https://www.statnews.com/2026/03/19/american-gene-therapy-leadership-challenged-speedy-china-trials/
STAT
Drug development is booming in China. Should the U.S. view it as a threat or an opportunity?
If the U.S. wants to hold on to its title as the world's top biotech innovator, it might want to take a page out of China's book, a pioneer in CAR-T cell therapy said on Thursday.